Close
Close

Magic™ Membrane Protein SARS-CoV-2 N Mutation (Omicron, B.1.1.529) (Surface glycoprotein) (CAT#: MPX4705K)

Datasheet
This product is a made-to-order SARS-CoV-2 omicron variant N Mutation (G204R, R203K) protein. The protein is for research use only and is not approved for use in humans or in clinical diagnosis.

Product Specifications

  • Host Species
  • SARS-CoV-2
  • Target Protein
  • N Mutation (Omicron, B.1.1.529)
  • Protein Class
  • Host-virus interaction
  • TMD
  • 1

Product Description

  • Tag
  • His tag at C-terminal

Target

  • Target Protein
  • N Mutation (Omicron, B.1.1.529)
  • Full Name
  • Nucleocapsid phosphoprotein
  • Introduction
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ The structural proteins of SARS-CoV-2 include the envelope protein (E), spike or surface glycoprotein (S), membrane protein (M) and the nucleocapsid protein (N). The nucleocapsid phosphoprotein is a structural protein that binds to, protects the viral RNA genome and is involved in packaging the RNA into virus particles. The N protein has been suggested as an antiviral drug target.
  • Alternative Names
  • N Mutation (B.1.1.529); ORF9; Omicron Variant; structural protein; Nucleocapsid phosphoprotein

Customer reviews and Q&As    

Related Products
Online Inquiry
CONTACT US
USA:
Europe:
Germany:
Call us at:
USA:
UK:
Germany:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2024 Creative Biolabs. | Contact Us